{'fraction_non_alphanumeric': 0.02666666666666667, 'fraction_numerical': 0.006666666666666667, 'mean_word_length': 5.632352941176471, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Effect of cisplatin in esophageal cancer with hepatic metastasis].

Cis-dichlorodiammineplatinum(II)(CDDP) was given to a patient with esophageal carcinoma who developed liver metastasis after radiotherapy, and partial response was obtained. Nephrotoxicity was observed when the total dose of CDDP reached to 300 mg. CDDP seems to be effective in the treatment of patient with distant metastasis during or after radiotherapy of esophageal carcinoma.